Michał Gniot (M Gniot, Michal Gniot)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Chronic Myeloid Leukemia

Mitochondrial Dna

Top Venues

OncoTargets and therapy

Leukemia & lymphoma

Annals of hematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Lewandowski Krzysztof, Zuzanna Kanduła, Michał Gniot, Edyta Paczkowska, Paulina Maria Nawrocka, Marzena Wojtaszewska, Michał Janowski, Magdalena Mariak, Luiza Handschuh, Kozłowski Piotr
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 101 (12) (2022)
Michał Janowski, Zofia Ulańczyk, Karolina Łuczkowska, Anna Sobuś, Dorota Rogińska, Ewa Pius-Sadowska, Michał Gniot, Krzysztof Kozłowski, Krzysztof Lewandowski, Grzegorz Helbig, Bogusław Machaliński, Edyta Paczkowska
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways. OncoTargets and therapy 15 (2022)
Helen E White, Matthew Salmon, Francesco Albano, Christina Søs Auður Andersen, Stefan Balabanov, Gueorgui Balatzenko, Gisela Barbany, Jean-Michel Cayuela, Nuno Cerveira, Pascale Cochaux, Dolors Colomer, Daniel Coriu, Joana Diamond, Christian Dietz, Stephanie Dulucq, Marie Engvall, Georg N Franke, Egle Gineikiene-Valentine, Michał Gniot, María Teresa Gómez-Casares, Enrico Gottardi, Chloe Hayden, Sandrine Hayette, Andreas Hedblom, Anca Ilea, Barbara Izzo, Antonio Jiménez-Velasco, Tomas Jurcek, Veli Kairisto, Stephen E Langabeer, Thomas Lion, Nora Meggyesi, Semir Mešanović, Luboslav Mihok, Gerlinde Mitterbauer-Hohendanner, Sylvia Moeckel, Nicole Naumann, Olivier Nibourel, Elisabeth Oppliger Leibundgut, Panayiotis Panayiotidis, Helena Podgornik, Christiane Pott, Inmaculada Rapado, Susan J Rose, Vivien Schäfer, Tasoula Touloumenidou, Christopher Veigaard, Bianca Venniker-Punt, Claudia Venturi, Paolo Vigneri, Ingvild Vorkinn, Elizabeth Wilkinson, Renata Zadro, Magdalena Zawada, Hana Zizkova, Martin C Müller, Susanne Saussele, Thomas Ernst, Katerina Machova Polakova, Andreas Hochhaus, Nicholas C P Cross
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia 36 (7) (2022)
Marzena Wojtaszewska, Rafał Stępień, Alicja Woźna, Maciej Piernik, Paweł Sztromwasser, Maciej Dąbrowski, Michał Gniot, Sławomir Szymański, Maciej W Socha, Piotr Kasprzak, Rafał Adam Matkowski, Pawel Zawadzki
Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach. Molecular diagnosis & therapy 26 (1) (2021)
Blazej Ratajczak, Michał Gniot, Anna Przybyłowicz-Chalecka, Joanna Czerwinska-Rybak, Mieczyslaw Komarnicki, Lewandowski Krzysztof, Malgorzata Jarmuz-Szymczak
Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study. Leukemia & lymphoma 61 (1) (2019)
Lewandowski Krzysztof, Michał Gniot, M Wojtaszewska, Z Kanduła, R Becht, E Paczkowska, E Mędraś, E Wasilewska, M Iwoła
Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. International journal of laboratory hematology 40 (3) (2018)
Tomasz Sacha, Joanna Góra-Tybor, Monika Szarejko, Grażyna Bober, Olga Grzybowska-Izydorczyk, Joanna Niesiobędzka-Krężel, Marek Dudziński, Ewa Wasilewska, Krzysztof Myśliwiec, Justyna Gil, Michał Gniot, Iwona Pietkun, Ewa Mędraś, Jadwiga Hołojda, Joanna Wącław, Krzysztof Giannopoulos
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry. American journal of hematology 92 (7) (2017)